PERFORMANCE EVALUATION OF MUCOADHESIVE POTENTIAL OF SODIUM ALGINATE ON MICROSPHERES CONTAINING AN ANTI-DIABETIC DRUG: GLIPIZIDE
Abstract
The objective of the present investigation was to design mucoadhesive microspheres to achieve a substantial increase in length of stay of the drug in the GI tract of glipizide for treatment of type 2 diabetes mellitus. Glipizide is a second-generation sulfonylurea derivative used for the treatment of type II diabetes. Its short biological half-life (0.3 ± 0.7 h) necessitates the need to be administered in two or three doses of 2.5-10 mg per day. Mucoadhesive microsphere exhibit a prolonged residence time at the site of application and facilitate an intimate contact with the underlying absorption surface and thus contribute to improved or better therapeutic performance of drug. It would, therefore be advantageous to have means for providing an intimate contact of the drug delivery system with the absorbing membranes. In the present study, alginate based mucoadhesive microspheres of were prepared by ionotropic external gelation technique utilizing calcium chloride (CaCl2) as a cross linking agent, to take the advantage of swelling and mucoadhesive property of alginate beads for improving the oral delivery of glipizide. Interaction studies performed using FTIR spectroscopy and DSC revealed that there was no drug to polymer interactions. The prepared microspheres are discrete, spherical and free flowing which was characterized by entrapment efficiency, particle size, micromeritic properties, in-vitro release behavior, scanning electron microscopy (SEM), in-vitro wash off test etc. Depending upon the variability in the concentration of sodium alginate, time of cross linking agent, the factors like particle size, and incorporation efficiency and release rate and mucoadhesion properties of microspheres varies. It was observed that increasing the polymer concentration along with the cross-linking time given the better affect on microspheres characteristic and percentage release of drug. Formulation F8 containing 5% w/v sodium alginate was selected as best formulation by considering its better % drug entrapment [84.31%] and flow properties [Carr’s index (8.204), angle of repose (31.15)].
Keywords:
Glipizide, mucoadhesive microspheres and ionotropic external gelation techniqueDOI
https://doi.org/10.25004/IJPSDR.2012.040205References
2. Ahuja A, Khar RK, Ali J. Mucoadhesive drug delivery systems. Drug. Dev. Ind. Pharm. 1997; 23(5): 489-515.
3. Gavini E, Rassu G, Sanna V, Cossu M, Giunchedi P. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in vitro/ex-vivo studies. J Pharm Pharmacol. 2005; 57(3): 287-294.
4. El-Gindy GA. Formulation development and in-vivo evaluation of buccoadhesive tablets of verapamil hydrochloride. Bull Pharm Sci. 2004; 27: 293-306.
5. Foster RH, Plosker GL. Glipizide: a review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus. Pharmacoeconomics 2000; 18: 289-306.
6. Chowdary KPR, Balatripura G. Design and in vitro evaluation of mucoadhesive controlled release oral tablets of glipizide. Ind J Pharm Sci. 2003; 65: 591-594.
7. Bhattacharya A, Maitra P, Mukherjee A. Alginate-based nanocapsular antineoplastic drug delivery system by pneumatic nebulization. Indian J. Pharm. Sci. 2003; 65(5): 477-481.
8. Belgamwar V, Shah V, Surana SJ. Formulation and evaluation of oral mucoadhesive multiparticulate system containing metoprolol tartarate: an in vitro-ex vivo characterization. Current Drug Delivery 2009; 6: 113-121.
9. Patil DA, Patil GB, Deshmukh PK, Belgamwar VS, Fursule RA. Chitosan coated mucoadhesive multiparticulate drug delivery system for gliclazide. Asian Journal of Pharmaceutical and Clinical Research 2009; 2(2): 62-68.
10. Mazumder R, Nath LK, Haque A, Maity T, Choudhury PK, Shrestha B, Chakraborty M, Pal RN. Formulation and in vitro evaluation of natural polymers based microspheres for colonic drug delivery. International J Pharm Pharmaceut Sci. 2010; 2 (1): 211-219.
11. Senthil A, Thakkar Hardik R, Sivakumar T, Jain DA. Formulation and evaluation of mucoadhesive glipizide microspheres using carboxy methyl cellulose. International Journal of Preclinical and Pharmaceutical Research 2011; 2(1): 45-51.
12. Michael EA, Pharmaceutics the Design and Manufacture of Medicines, 3rd ed., Churchill Livingstone Elsevier, New York, USA 2007.
13. Chowdary KPR, Srinivasa YR. Mucoadhesive microcapsules of glipizide: in vitro and in vivo ealuation. Ind J Pharm Sci. 2003; 65(3): 279-284.
14. Anandrao RK, Kumaresh SS, Tejraj MA, Walter ER. In-vitro Release kinetics of cefadroxil-loaded sodium alginate interpenetrating network beads. Eur. J. Pharm. Biopharm. 2001; 51: 127-33.
Published
Abstract Display: 363 
PDF Downloads: 435 
